Stroke, Vol 13, 519-521, Copyright © 1982 by American Heart Association
DJ Macey, LJ Filipow, ST McCarthy and M Pitkanen
A problem in the measurement of cerebral blood flow with 133Xenon is the
presence of extra-cerebral counts in the total counts recorded with a
collimated gamma ray detector looking at the brain. A method of studying
qualitatively the contribution of this extra-cranial component in patients
is described. This entails the sequential accumulation of gamma ray spectra
recorded during the clearance phase of 133Xenon from the brain. It is shown
that different CBF indices are obtained for various regions of the recorded
gamma ray spectra. The principal component of the extra-cerebral counts at
15 minutes postinjection appears to be intra-cranial, and not the scalp as
assumed previously in the spectrum subtraction method.
ARTICLES
Analysis of the gamma ray spectra recorded in the use of Xenon-133 for cerebral blood flow studies
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1982 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |